Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mirabegron vs Tamsulosin vs Solifenacin for Ureteral Stent Symptoms
NCT04325880Phase 3Unknown
- Sponsor
- Mansoura University
- Start
- Dec 2021
- Primary completion
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of mirabegron in ureteral stent-related symptoms (USRS), sponsored by Mansoura University. Status: unknown.
02
Drugs
mirabegron
03
Conditions
ureteral stent-related symptoms (USRS)
Beyond the preview
Go deeper on NCT04325880.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04325880.